152 related articles for article (PubMed ID: 17201146)
61. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
[TBL] [Abstract][Full Text] [Related]
62. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma.
Lung HL; Bangarusamy DK; Xie D; Cheung AK; Cheng Y; Kumaran MK; Miller L; Liu ET; Guan XY; Sham JS; Fang Y; Li L; Wang N; Protopopov AI; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
Oncogene; 2005 Sep; 24(43):6525-32. PubMed ID: 16007174
[TBL] [Abstract][Full Text] [Related]
63. Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma.
Tian F; Yip SP; Kwong DL; Lin Z; Yang Z; Wu VW
Cancer Epidemiol; 2013 Oct; 37(5):708-13. PubMed ID: 23790641
[TBL] [Abstract][Full Text] [Related]
64. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.
Lau QC; Raja E; Salto-Tellez M; Liu Q; Ito K; Inoue M; Putti TC; Loh M; Ko TK; Huang C; Bhalla KN; Zhu T; Ito Y; Sukumar S
Cancer Res; 2006 Jul; 66(13):6512-20. PubMed ID: 16818622
[TBL] [Abstract][Full Text] [Related]
65. Aberrant promoter hypermethylation in biliary tract carcinoma.
Kohya N; Koga Y; Kitajima Y; Miyazaki K
J Hepatobiliary Pancreat Surg; 2006; 13(4):296-305. PubMed ID: 16858540
[TBL] [Abstract][Full Text] [Related]
66. Specific reversal of tumor-suppressor gene promoter hypermethylation with bovine oocyte extract.
Wang Z; Gao H; Wang H; Ren X; Bao L; Sa R; Wang J; Bai H; Yu H
Oncol Rep; 2013 Jul; 30(1):179-84. PubMed ID: 23670097
[TBL] [Abstract][Full Text] [Related]
67. [Improvement and application of methylation-specific polymerase chain reaction].
Xiao WH; Liu WW
Ai Zheng; 2004 Nov; 23(11):1354-6. PubMed ID: 15522190
[TBL] [Abstract][Full Text] [Related]
68. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
69. Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancer.
Hibi K; Nakao A
Anticancer Res; 2006; 26(1A):55-8. PubMed ID: 16475679
[TBL] [Abstract][Full Text] [Related]
70. Identification of RASSF1A modulated genes in nasopharyngeal carcinoma.
Chow LS; Lam CW; Chan SY; Tsao SW; To KF; Tong SF; Hung WK; Dammann R; Huang DP; Lo KW
Oncogene; 2006 Jan; 25(2):310-6. PubMed ID: 16116475
[TBL] [Abstract][Full Text] [Related]
71. Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma.
Shiraha H; Nishina S; Yamamoto K
J Cell Biochem; 2011 Mar; 112(3):745-9. PubMed ID: 21328447
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient.
Chang HW; Chan A; Kwong DL; Wei WI; Sham JS; Yuen AP
Int J Cancer; 2003 Jul; 105(6):851-5. PubMed ID: 12767073
[TBL] [Abstract][Full Text] [Related]
73. Cancer research. Dispute over tumor suppressor gene Runx3 boils over.
Normile D
Science; 2011 Oct; 334(6055):442-3. PubMed ID: 22034407
[No Abstract] [Full Text] [Related]
74. Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line.
Wongpaiboonwattana W; Tosukhowong P; Dissayabutra T; Mutirangura A; Boonla C
Asian Pac J Cancer Prev; 2013; 14(6):3773-8. PubMed ID: 23886181
[TBL] [Abstract][Full Text] [Related]
75. Use of low-melting-point primers for bisulfite genomic sequencing: analysis of the H37 lung cancer tumor suppressor gene promoter.
Oh JJ; Boctor B; Jimenez CA; Lopez RC; Razfar A; Slamon DJ
Anal Biochem; 2005 Aug; 343(2):347-9. PubMed ID: 15992761
[No Abstract] [Full Text] [Related]
76. Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas.
Carvalho R; Milne AN; Polak M; Corver WE; Offerhaus GJ; Weterman MA
Oncogene; 2005 Dec; 24(56):8252-8. PubMed ID: 16091737
[TBL] [Abstract][Full Text] [Related]
77. DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade.
Majchrzak-Celińska A; Paluszczak J; Szalata M; Barciszewska AM; Nowak S; Baer-Dubowska W
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1593-601. PubMed ID: 25648363
[TBL] [Abstract][Full Text] [Related]
78. [Correlation between the methylation status of Runx3 gene and positive expression of estrogen receptor in breast cancer].
Yan Z; Gao S; Wu X; Liu H
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):240-4. PubMed ID: 25975905
[TBL] [Abstract][Full Text] [Related]
79. Methylation of RUNX3 and RASSF1A and the risk of Malignancy in small solitary pulmonary nodules.
Zhao J; Cui X; Huang X; Lu R; Chen P; Zhang Z
J Cancer Res Ther; 2019; 15(4):899-903. PubMed ID: 31436249
[TBL] [Abstract][Full Text] [Related]
80. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma.
Lo KW; Tsang YS; Kwong J; To KF; Teo PM; Huang DP
Int J Cancer; 2002 Apr; 98(5):651-5. PubMed ID: 11920632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
